BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10554797)

  • 1. Accelerated telomere shortening and telomerase activation in Fanconi's anaemia.
    Leteurtre F; Li X; Guardiola P; Le Roux G; Sergère JC; Richard P; Carosella ED; Gluckman E
    Br J Haematol; 1999 Jun; 105(4):883-93. PubMed ID: 10554797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia.
    Li X; Leteurtre F; Rocha V; Guardiola P; Berger R; Daniel MT; Noguera MH; Maarek O; Roux GL; de la Salmonière P; Richard P; Gluckman E
    Br J Haematol; 2003 Mar; 120(5):836-45. PubMed ID: 12614219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere shortening in Fanconi anaemia demonstrated by a direct FISH approach.
    Hanson H; Mathew CG; Docherty Z; Mackie Ogilvie C
    Cytogenet Cell Genet; 2001; 93(3-4):203-6. PubMed ID: 11528113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe telomere shortening in Fanconi anemia complementation group L.
    Shah A; George M; Dhangar S; Rajendran A; Mohan S; Vundinti BR
    Mol Biol Rep; 2021 Jan; 48(1):585-593. PubMed ID: 33394227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
    Polychronopoulou S; Koutroumba P
    Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia.
    Callén E; Samper E; Ramírez MJ; Creus A; Marcos R; Ortega JJ; Olivé T; Badell I; Blasco MA; Surrallés J
    Hum Mol Genet; 2002 Feb; 11(4):439-44. PubMed ID: 11854176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
    Engelhardt M; Ozkaynak MF; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore MA
    Leukemia; 1998 Jan; 12(1):13-24. PubMed ID: 9436916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between chromosome fragility, aneuploidy and severity of the haematological disease in Fanconi anaemia.
    Callén E; Ramírez MJ; Creus A; Marcos R; Ortega JJ; Olivé T; Badell I; Surrallés J
    Mutat Res; 2002 Jul; 504(1-2):75-83. PubMed ID: 12106648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of mutations in the human telomerase RNA component (hTERC) gene in Fanconi's anemia.
    Calado RT; Pintão MC; Rocha V; Falcão RP; Bitencourt MA; Silva WA; Gluckman E; Pasquini R; Zago MA
    Haematologica; 2004 Aug; 89(8):1012-3. PubMed ID: 15339688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
    Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M
    Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere dynamics in Fancg-deficient mouse and human cells.
    Franco S; van de Vrugt HJ; Fernández P; Aracil M; Arwert F; Blasco MA
    Blood; 2004 Dec; 104(13):3927-35. PubMed ID: 15319283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive telomere shortening in aplastic anemia.
    Ball SE; Gibson FM; Rizzo S; Tooze JA; Marsh JC; Gordon-Smith EC
    Blood; 1998 May; 91(10):3582-92. PubMed ID: 9572992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress causes telomere damage in Fanconi anaemia cells - a possible predisposition for malignant transformation.
    Uziel O; Reshef H; Ravid A; Fabian I; Halperin D; Ram R; Bakhanashvili M; Nordenberg J; Lahav M
    Br J Haematol; 2008 Jul; 142(1):82-93. PubMed ID: 18477050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal chromosomal abnormalities in Fanconi's anaemia: what do they really mean?
    Alter BP; Scalise A; McCombs J; Najfeld V
    Br J Haematol; 1993 Nov; 85(3):627-30. PubMed ID: 8136289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chromosome abnormalities in bone marrow cells and peripheral lymphocytes in a patient with Fanconi's anemia].
    Margiotta G; Barbata G; Carbone P; Granata G; Caronia F
    Minerva Med; 1981 Sep; 72(35):2361-5. PubMed ID: 7279258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations.
    Dokal I; Chase A; Morgan NV; Coulthard S; Hall G; Mathew CG; Roberts I
    Br J Haematol; 1996 Jun; 93(4):813-6. PubMed ID: 8703809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeric length in individuals and cell lines with altered p53 status.
    Kruk PA; Bohr VA
    Radiat Oncol Investig; 1999; 7(1):13-21. PubMed ID: 10030619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia.
    Joenje H; Arwert F; Eriksson AW; de Koning H; Oostra AB
    Nature; 1981 Mar; 290(5802):142-3. PubMed ID: 7207594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fanconi's anemia. Incidence of its development into leukemia].
    Schaison G; Leverger G; Yildiz C; Berger R; Bernheim A; Gluckman E
    Presse Med; 1983 May; 12(20):1269-74. PubMed ID: 6222298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.